NP Life Sciences Health Industry Group annual ebitda
2021
2022
2023
NP Life Sciences Health Industry Group EBITDA Growth & History (ACAT)
NP Life Sciences Health Industry Group's calculated EBITDA was −$690 for fiscal 2023.
View full NP Life Sciences Health Industry Group company overviewNP Life Sciences Health Industry Group annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | −$690 | $18,165 | — |
| 2022 | 2022-12-31 | −$18,855 | $46,826 | — |
| 2021 | 2021-12-31 | −$65,681 | — | — |
NP Life Sciences Health Industry Group quarterly ebitda
Q1.25
Q2.25
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2025 | 2025-06-30 | −$21,683 | — | — |
| Q1 2025 | 2025-03-31 | −$623 | — | — |
NP Life Sciences Health Industry Group ebitda trends
Between the periods ended 2021-12-31 and 2023-12-31, NP Life Sciences Health Industry Group's ebitda increased from −$65,681 to −$690, a change of $64,991. The latest reported quarter, Q2 2025, shows −$21,683.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NP Life Sciences Health Industry Group source filings ↗